Click HERE to download the PDF version

AAIPharma Services Corporation (AAI)/Cambridge Major Laboratories, Inc. (CML), a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, during DCAT Week 16 in New York announced its new brand and identity as a leading contract development and manufacturing organization (CDMO) with expanded capabilities and capacity, the organization to now be known as “Alcami”.
Originally joined together in late 2013, AAI and CML combined to offer analytical testing and development services for active pharmaceutical ingredients (APIs) with oral solid and parenteral dose finished product capacity. Providing an integrated offering for both drug substance and drug product at every development stage beginning with solid state chemistry and formulation development, Alcami believes they have created a robust new outsourcing offering.
Alcami has recently announced significant investments in additional capabilities and capacity for oral solid dose man ...